Word: omnimedia
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...that would create a difficult choice for the Princess of Propriety: testify at the risk of contradicting herself under oath or assert her Fifth Amendment right against self-incrimination. The latter is her legal privilege, but would do nothing to help the stock of her company, Martha Stewart Living Omnimedia, which has fallen 65% since the ImClone news broke...
...explanation of why, after buying stock in a drug company run by a close friend, she sold her shares just ahead of bad news about the company's cancer drug. Stewart, recently appointed a director of the New York Stock Exchange, denies wrongdoing, but shares in her Martha Stewart Omnimedia have declined 40% in the past month over fears of damage to her image...
Stewart had no public comment on Faneuil's allegations. But, alarmed by the precipitous decline in the stock of her company, Martha Stewart Living Omnimedia, she unexpectedly turned up at a conference for institutional investors at Chicago's Four Seasons Hotel and talked up the prospects for her magazine, which has been showing strong advertising growth. Many investors are staying on the sidelines until Stewart is clear of the ImClone case...
...widely known as a close friend of Waksal's, and documents provided to congressional investigators revealed that she had sold $228,000 worth of ImClone stock the day before the FDA announced the bad news about Erbitux. Stewart denied any wrongdoing, but shares in Martha Stewart Living Omnimedia have plunged 19% since the news broke, on fears that her image would be sullied by association with Waksal and ImClone...
...promising cancer drug-was "proper and lawful." Her company also announced a 26% jump in ad pages for the July issue of Martha Stewart Living. Say this for the woman who turns old drawer pulls into fancy wine corks: She knows her audience. Shares of Martha Stewart Living Omnimedia, in which she has a 63% stake worth nearly $500 million, recovered to $15.97 Friday after a two-week slide that had taken it down to $14.40 amid fears that her brand would be sullied by connection to insider-trading allegations at ImClone...